RxDoctor Payments Data

Inna Husain, MD

Otolaryngology · Munster, INNPI 1669769295

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,244 of the $12,970 with a category attached, or 79.0%. 10 manufacturers reported payments, led by Smith+Nephew at 59.5% of the total. Reporting peaked in 2024 at $10,048 and has fallen 73.3% since, to $2,681 in 2025. Among otolaryngology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,970in general payments, 2019–2025

Across 25 payments — averaging $518.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$8K
  • Integra Lifesciences Corporation$4K
  • Acclarent, Inc$236
  • Stryker$129
  • Inspire Medical Systems, Inc.$127
  • Aerin Medical Inc.$109
  • plus $230 from 4 others

What the payments were for

  • Consulting fees$10,24479%
  • Travel & lodging$1,75914%
  • Food & beverage$9687%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,970 in reported general payments places this provider in the 90th percentile of 193 otolaryngology providers in Indiana.

See all otolaryngology providers in Indiana

Medicare billing

Part B allowed, 2024
$101,696
Medicare patients
341
Services billed
1,080

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl74$1,787
Fluticasone Propionate37$454
Omeprazole30$220
Pantoprazole Sodium24$204
Ipratropium Bromide11$184
Famotidine14$100

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Munster

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →